CINF
48
-5
CFG
89
-4
AAP
45
3
BRK.B
33
-3
ADM
47
-4
CNP
52
2
CMCSA
46
7
AAPL
45
-3
VIX
57
13
APH
64
-3
APD
54
-3
CCI
42
-4
AEE
64
-2
BEN
57
11
CTAS
46
-3
CL
58
-12
AIV
51
-2
C
81
-3
ADT
71
-2
CI
53
-6
CINF
48
-5
CFG
89
-4
AAP
45
3
BRK.B
33
-3
ADM
47
-4
CNP
52
2
CMCSA
46
7
AAPL
45
-3
VIX
57
13
APH
64
-3
APD
54
-3
CCI
42
-4
AEE
64
-2
BEN
57
11
CTAS
46
-3
CL
58
-12
AIV
51
-2
C
81
-3
ADT
71
-2
CI
53
-6
Financhill
Back

Cidara Therapeutics 10K Form

Buy
81

CDTX
Cidara Therapeutics

Last Price:
$50.49
Seasonality Move:
0.55%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CDTX News And Ratings

See the #1 stock for the next 7 days that we like better than CDTX

CDTX Financial Statistics

Sales & Book Value

Annual Sales: $1.3M
Cash Flow: $-22M
Price / Cash Flow: 0
Annual Sales: $11.60
Price / Book: 7.13

Profitability

EPS (TTM): -29.47000
Net Income (TTM): $-183M
Gross Margin: $62.4M
Return on Equity: -443.37%
Return on Assets: -134.09%

Cidara Therapeutics Earnings Forecast

Key Cidara Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 5 years for CDTX is 267.93%.
  • The Selling, General & Administrative Expenses for CDTX have been equal to 1,616.86% of Gross Profit Margin.
  • The Research & Development expenses have been 12,295.06% of Revenue.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Cidara Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CDTX
CUSIP: 171757
Website: cidara.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.25
Quick Ratio: 4.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CDTX Technical Analysis vs Fundamental Analysis

Buy
81
Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy or a Sell?